InsiderTrades

Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001628280-24-007994 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-29 2024-02-27 AMRX Shah Nikita EVP F - Tax $5.71 -18.7K 336.9K -5% -$106.6K
D 2024-02-29 2024-02-27 AMRX Shah Nikita EVP M - OptEx — +35.6K 355.6K +11% —
D 2024-02-29 2024-02-27 AMRX Shah Nikita EVP M - OptEx $0.00 -35.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-02-27 F D 18,670 $5.71 336,922 D — — (F3) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
2 Common Class A Common Stock 2024-02-27 M A 35,620 — 355,592 D — — (F1) Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
3 Derivative Restricted Stock Units 2024-02-27 M D 35,620 $0.00 0 D — · — to — 35,620 Class A Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.